findmyKOL

Ladan Golestaneh, MD

Basic profile

Nephrology

ORCID↗NPI↗
✓ Full record
RegionNew Haven, CT · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ladan Golestaneh is a Nephrology physician. OpenAlex indexes 131 publications with 6,354 citations (h-index 32).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
131publications

Distinct works indexed by OpenAlex, matched via ORCID.

6,354citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

20 York St
New Haven, CT 065103220

Telephone

203-785-4184

Provider last certified this registry record 8 Aug 2024.

View the NPPES registry record

Industry payments

4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    59.5%
    Calcium channel blocker16.9%
    Nifedipine Er63%Amlodipine Besylate37%
    Part D≥23 patients
    Loop diuretic9.8%
    Furosemide100%
    Part D≥17 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    13.9%
    Vitamin D3 Analog6.6%
    Calcitriol100%
    Part D≥13 patients
    SGLT2 inhibitor4.6%
    Jardiance52%Farxiga48%
    Part D<11 patients

    + 1 more class in this area

  • Other

    6.6%
    Phosphate Binder6.6%
    Sevelamer Carbonate100%
    Part D≥12 patients
Where care is delivered (Part B)91.1% facility · 8.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”